dc.contributor.author | Sweeney, Martin | en |
dc.contributor.author | Coyle, Robert | en |
dc.contributor.author | Kavanagh, Paul | en |
dc.contributor.author | Berezin, Andrey A. | en |
dc.contributor.author | Lo Re, Daniele | en |
dc.contributor.author | Zissimou, Georgia A. | en |
dc.contributor.author | Koutentis, Panayiotis Andreas | en |
dc.contributor.author | Carty, Michael P. | en |
dc.contributor.author | Aldabbagh, Fawaz | en |
dc.creator | Sweeney, Martin | en |
dc.creator | Coyle, Robert | en |
dc.creator | Kavanagh, Paul | en |
dc.creator | Berezin, Andrey A. | en |
dc.creator | Lo Re, Daniele | en |
dc.creator | Zissimou, Georgia A. | en |
dc.creator | Koutentis, Panayiotis Andreas | en |
dc.creator | Carty, Michael P. | en |
dc.creator | Aldabbagh, Fawaz | en |
dc.date.accessioned | 2019-11-21T06:23:04Z | |
dc.date.available | 2019-11-21T06:23:04Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | http://gnosis.library.ucy.ac.cy/handle/7/56182 | |
dc.source.uri | https://nls.ldls.org.uk/welcome.html?ark:/81055/vdc_100034348639.0x00002a | |
dc.subject | Biochemistry | en |
dc.subject | Pharmaceutical chemistry | en |
dc.subject | Chemistry, Organic | en |
dc.subject | Bioorganic chemistry | en |
dc.subject | Chemistry, Clinical | en |
dc.subject | Chimie bio-organique | en |
dc.subject | Périodiques | fr |
dc.subject | Chimie pharmaceutique | fr |
dc.title | Discovery of anti-cancer activity for benzo1,2,4]triazin-7-ones: Very strong correlation to pleurotin and thioredoxin reductase inhibition | en |
dc.type | info:eu-repo/semantics/article | |
dc.author.faculty | 002 Σχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences | |
dc.author.department | Τμήμα Χημείας / Department of Chemistry | |
dc.type.uhtype | Article | en |
dc.description.notes | <p>ID: 1083 | en |
dc.description.notes | In: Bioorganic & medicinal chemistry, Vol. 24, no. 16 ( 2016), p.3565-3570. | en |
dc.description.notes | Summary: Graphical abstractAbstractThe thioredoxin (Trx)–thioredoxin reductase (TrxR) system plays a key role in maintaining the cellular redox balance with Trx being over-expressed in a number of cancers. Inhibition of TrxR is an important strategy for anti-cancer drug discovery. The natural product pleurotin is a well-known irreversible inhibitor of TrxR. The cytotoxicity data for benzo[1,2,4]triazin-7-ones showed very strong correlation (Pearson correlation coefficients ∼0.8) to pleurotin using National Cancer Institute COMPARE analysis. A new 3-CF3substituted benzo[1,2,4]triazin-7-one gave submicromolar inhibition of TrxR, although the parent compound 1,3-diphenylbenzo[1,2,4]triazin-7-one was more cytotoxic against cancer cell lines. Benzo[1,2,4]triazin-7-ones exhibited different types of reversible inhibition of TrxR, and cyclic voltammetry showed characteristic quasi-reversible redox processes. Cell viability studies indicated strong dependence of cytotoxicity on substitution at the 6-position of the 1,3-diphenylbenzo[1,2,4]triazin-7-one ring.</p> | en |
dc.contributor.orcid | Koutentis, Panayiotis Andreas [0000-0002-4652-7567] | |
dc.contributor.orcid | Zissimou, Georgia A. [0000-0003-4821-9469] | |
dc.gnosis.orcid | 0000-0002-4652-7567 | |
dc.gnosis.orcid | 0000-0003-4821-9469 | |